Body Water Content in Cyanotic Congenital Heart Disease
2 other identifiers
observational
N/A
1 country
1
Brief Summary
Adults with cyanotic congenital heart disease have elevated levels of plasma proatrial natruretic peptide (proANP) which most likely results in chronic dehydration, leading to reduced oxygen transport to tissues and shortness of breath with activity. The purpose of this study is to characterize adults with cyanotic congenital heart defects with respect to their body composition (water and fat-free mass) and resting metabolic rates. The study consists of several measures of how much body water, fat and lean tissue a subject has, and measures the number of calories the subject's body uses at rest. Adult subjects with cyanotic congenital heart disease will be recruited along with healthy noncyanotic control subjects matched for age, gender, and body weight.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 18, 2000
CompletedFirst Posted
Study publicly available on registry
January 19, 2000
CompletedJune 24, 2005
December 1, 2003
January 18, 2000
June 23, 2005
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Resting blood pressure below 140/90
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Vermont
Burlington, Vermont, 05401, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Sponsor Type
- NIH
Study Record Dates
First Submitted
January 18, 2000
First Posted
January 19, 2000
Last Updated
June 24, 2005
Record last verified: 2003-12